Wave Life Sciences (WVE) Current Assets (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Current Assets data on file, last reported at $507.5 million in Q2 2026.

• Quarterly Current Assets rose 127.02% year-over-year to $507.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $507.5 million (up 127.02% YoY) and the FY2025 annual result came in at $614.8 million, up 91.89% from the prior year.
• Current Assets fell to $507.5 million in Q2 2026, from $561.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $614.8 million in Q4 2025 to a low of $98.5 million in Q4 2022.
• A 5-year average of $261.5 million and a median of $217.5 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets sank 39.39% — and 2023, when it surged 138.87%.
• Tracing WVE's Current Assets over 5 years: stood at $98.5 million in 2022, then surged by 138.87% to $235.4 million in 2023, then surged by 36.12% to $320.4 million in 2024, then soared by 91.89% to $614.8 million in 2025, then fell by 17.45% to $507.5 million in 2026.
• The last three Current Assets figures came in at $507.5 million (Q2 2026), $561.3 million (Q1 2026), and $614.8 million (Q4 2025), per Business Quant data.